eversyn

Nucleotide Sugars & Oligosaccharides for Nutrition & Pharmaceutical Applications: Our proprietary technology is based on the efficient use of novel, GMO-free biocatalytic cascades. We have designed and engineered these pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins.

eversyn is a spin-off of the Max Planck Institute Magdeburg - run, founded and supported by current and former Max Planck scientists and business professionals. Together we are highly skilled, experienced and motivated team of scientist, industrial and business professionals. We have an excellent track record of successfully working together at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, manifested by numerous patents and high-profile publications and collaborations. While we are international team with diverse sets of skills and backgrounds, we share the tenacity and grit that will make eversyn a success.